Abstract
To perform a review on patients with primary antiphospholipid syndrome (APS) who developed an aneurysm. A review of articles published in PubMed/MEDLINE, LILACS, and SciELO dating from 1966 to October 2020 was conducted using the following search words: “Antiphospholipid syndrome” and “aneurysm.” No language limitation was applied. This review includes 10 articles on APS patients and aneurysms entailing 14, including our additional case. Age varied from 20 to 76 years old, and female sex was predominant and presented in 54%. The arterial vessels compromised were aorta (n = 6), coronary (n = 2), hepatic (n = 2), renal (n = 2), middle cerebral artery (n = 2), and then splenic, superior mesenteric, pancreatic, retinal, jejunal, carotid, and pulmonary. Frequencies of antiphospholipid antibodies were described as follows: lupus anticoagulant (n = 6), anti-beta2-glycoprotein I (n = 4), IgG and IgM anticardiolipin (n = 3), IgG anticardiolipin (n = 3), and antiphosphatidylserine (n = 2). The presence of APS manifestations was distributed as deep venous thrombosis (n = 4), recurrent abortions (n = 4), pulmonary embolism (n = 3), stroke, or transitory ischemic accident (n = 3), and then limb ischemia and thrombocytopenia. The therapies used in these patients were warfarin, antiplatelet agent, vascular surgery, heparin, hydroxychloroquine, coil embolism, and intravenous immunoglobulin. Regarding outcomes, 5 patients were alive, and 3 were dead. This article reviewed all published cases on APS and aneurysm and showed that women who presented with abortions and deep venous thromboses with a lupus anticoagulant are those patients more commonly affected by aneurysms in APS.
Similar content being viewed by others
References
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
Carvalho JF (2008) Some concerns about the Sydney criteria for antiphospholipid syndrome. Lupus 17:770. https://doi.org/10.1177/0961203308093459
da Silva FF, Levy RA, de Carvalho JF (2014) Cardiovascular risk factors in the antiphospholipid syndrome. J Immunol Res 621270:1–6. https://doi.org/10.1155/2014/621270
George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y (1998) Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 98:1108–1115. https://doi.org/10.1161/01.cir.98.11.1108
Szyper-Kravitz M, Altman A, de Carvalho JF, Bellisai F, Galeazzi M, Eshet Y, Shoenfeld Y (2008) Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm. Isr Med Assoc J 10:48–51
Soldán-Patiño CP, Rojas-Velasco G, Arias-Mendoza MA, Enríquez-Gómez E, Meave-González A, Álvarez-Sangabriel A, Amigo MC, Vargas-Barrón J, Martínez-Sánchez CR (2012) Aneurisma de tronco de coronaria izquierda y síndrome antifosfolípido: sobrevida a 12 años. Informe de un caso y revisión de la literatura [Left main coronary aneurysm and antiphospholipid syndrome: survival at 12 years. A case report and literature review]. Arch Cardiol Mex 82:120–124
Sahin MA, Guler A, Demirkol S, Cagdas Yuksel U (2012) Huge coronary artery pseudoaneurysm in a young male patient with antiphospholipid syndrome. Eur J Cardiothorac Surg 41:708. https://doi.org/10.1093/ejcts/ezr011
Kurz DE, Wang RC, Kurz PA (2012) Idiopathic retinal vasculitis, aneurysms, and neuroretinitis in a patient with antiphospholipid syndrome. Arch Ophthalmol 130:257–258. https://doi.org/10.1001/archopthalmol.2011.1363
Paliogiannis P, Ginesu GC, Feo CF, Cossu ML, Pinna A, Farina G, Vidili G, Porcu A (2016) Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity. Ann Ital Chir 20;5:S2239253X16026104
Schoonjans R, Van Vlem B, Weyers S et al (1996) Polyarteritis nodosa and the antiphospholipid syndrome. Clin Rheumatol 15:410–413. https://doi.org/10.1007/BF02230368
Carrión-Barberà I, Zuccarino F, Escalante FA, Salman-Monte TC (2020) Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review. Clin Rheumatol. https://doi.org/10.1007/s10067-020-05313-y
Szpak GM, Kuczynska-Zardzewialy A, Popow A (1996) Brain vascular changes in the case of primary antiphospholipid syndrome. Folia Neuropathol 34:92–96
Dongola NA, Foord KD (2000) Angiographic features associated with antiphospholipid syndrome. Br J Radiol 73:1215–1218
Chung MH, Lee HG, Kwon SS, Kim YS, Park SH (2002) Pulmonary arterial aneurysms in primary antiphospholipid antibody syndrome. J Comput Assist Tomogr 26:608–612
Koutoulidis V, Chatziioannou A, Kostopoulus C et al (2005) Primary antiphospholipid syndrome: a unique presentation with multiple visceral aneurysms. Ann Rheum Dis 64:1793–1794
Moroz P, Le MT, Norman PE (2007) Homocysteine and abdominal aortic aneurysms. ANZ J Surg 77:329–332. https://doi.org/10.1111/j.1445-2197.2007.04052.x
Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E (1999) Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A 96:5164–5168
Meroni PL, Borghi MO, Lonati L, Sarzi Puttini P, Tincani A, Cugno M, Mari A (2004) Endothelial dysfunction in patients suffering from the antiphospholipid syndrome. Autoimmun Rev 3:585–586
Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G (2001) Antiphospholipid antibodies and the endothelium. Rheum Dis Clin N Am 27:587–602
Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW (2000) Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B), suppresses development of experimental abdominal aortic aneurysm. J Clin Invest 105:1641–1649
Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E (2002) Activity of matrix metalloproteinase-9 in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 127:393–398
Author information
Authors and Affiliations
Contributions
JFC: conception, analysis, writing, interpretation, revision, submission
YS: analysis, writing, interpretation, revision, submission
Corresponding author
Ethics declarations
Disclosures
None.
Ethical statement
The authors declare that they followed the World Medical Association Declaration of Helsinki in this study. An informed consent was obtained from the patient for publication of his case.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Carvalho, J.F., Shoenfeld, Y. Aneurysms in primary antiphospholipid syndrome: a case-based review. Clin Rheumatol 40, 3001–3006 (2021). https://doi.org/10.1007/s10067-020-05564-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05564-9